Charting the path to expanded access for CFTR modulator drugs: the nose knows

被引：3
|
作者：
Bear, Christine [1 ,2 ]
Ratjen, Felix [2 ,3 ,4 ]
机构：
[1] Hosp Sick Children, Res Inst, Mol Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[3] Hosp Sick Children, Res Inst, Translat Med, Toronto, ON, Canada
[4] Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷 / 04期
关键词：
CYSTIC-FIBROSIS; ORGANOIDS;
D O I：
10.1183/13993003.01387-2023
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
    Holbein, M. E. Blair
    Berglund, Jelena P.
    Weatherwax, Kevin
    Gerber, David E.
    Adamo, Joan E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2015, 8 (05): : 526 - 532
  • [22] Expanding access to safe abortion in DRC: charting the path from decriminalisation to accessible care
    Glover, Annie L.
    Mulunda, Jean-Claude
    Akilimali, Pierre
    Kayembe, Dynah
    Bertrand, Jane T.
    SEXUAL AND REPRODUCTIVE HEALTH MATTERS, 2023, 31 (01)
  • [23] Perspectives of Academic Oncologists About Offering Expanded Access to Investigational Drugs
    Gould, Patrick
    Salam, Tasnim
    Kimberly, Laura
    Bateman-House, Alison
    Lynch, Holly Fernandez
    JAMA NETWORK OPEN, 2022, 5 (11) : e2239766
  • [24] Overcoming health disparities in access to CFTR modulator therapies: One child's journey with cystic fibrosis
    Januska, Megan N.
    Langfelder-Schwind, Elinor
    Berdella, Maria N.
    PEDIATRIC PULMONOLOGY, 2022, 57 (09) : 2273 - 2275
  • [25] PARTNERING PEER SPECIALISTS WITH NURSES TO EXPAND ACCESS TO HEPATITIS C CARE FOR PEOPLE WHO INJECT DRUGS: THE PATH-EXPANDED MODEL EVALUATION
    O'Keefe, Daniel
    Armstrong, Stuart
    Bamford, Samuel
    Weidner, Caroline
    Dicka, Jane
    Crawford, Sione
    Watkinson, Sally
    Sasadeusz, Joe
    Scott, Alexandra
    Layton, Chloe
    Gold, Judy
    Elsum, Imogen
    Bryant, Melissa
    Gunn, Jack
    Doyle, Joseph
    Stoove, Mark
    Hellard, Margaret
    Pedrana, Alisa
    DRUG AND ALCOHOL REVIEW, 2021, 40 : S114 - S115
  • [26] The 'false hope' argument in discussions on expanded access to investigational drugs: a critical assessment
    Hordijk, Marjolijn
    Vermeulen, Stefan F.
    Bunnik, Eline M.
    MEDICINE HEALTH CARE AND PHILOSOPHY, 2022, 25 (04) : 693 - 701
  • [27] Therapeutic uses of investigational drugs: research extension, compassionate use, and expanded access
    Goldim, Jose Roberto
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2008, 23 (03): : 198 - 206
  • [28] Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis
    Horsburgh, C. R., Jr.
    Haxaire-Theeuwes, M.
    Lienhardt, C.
    Wingfield, C.
    McNeeley, D.
    Pyne-Mercier, L.
    Keshavjee, S.
    Varaine, F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (02) : 146 - 152
  • [29] The ‘false hope’ argument in discussions on expanded access to investigational drugs: a critical assessment
    Marjolijn Hordijk
    Stefan F. Vermeulen
    Eline M. Bunnik
    Medicine, Health Care and Philosophy, 2022, 25 : 693 - 701
  • [30] Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits
    Fountzilas, Elena
    Said, Rabih
    Tsimberidou, Apostolia M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (02) : 155 - 162
12345